The dorsal CA3 region of the hippocampus is unique in its connectivity, sensitivity to neurotoxic lesions, and its ability to encode and retrieve episodic memories. Computational models of the CA3 region predict that blocking mossy-fiber and/or perforant path activity to CA3 would cause impairments in learning and recall of spatial memory, respectively. Because the CA3 region contains -opioid receptors and receives inputs from the mossy-fiber and lateral perforant pathways, both of which contain and release opioid peptides, we tested the hypothesis that inactivating -opioid receptors in the CA3 region would cause spatial learning and memory impairments and retrieval deficits. In this study, male Sprague Dawley rats were trained in a Morris water maze after a single bilateral intrahippocampal injection of either saline or the selective and irreversible -opioid receptor antagonist ␤-funaltrexamine (␤-FNA) into area CA3. We found that -opioid receptor binding decreased 24 hr after ␤-FNA injection and returned to control levels 11 d after injection. Injections of ␤-FNA into the CA3 region, but not into the ventricles, caused a significant impairment in the acquisition of spatial learning without causing sensory or motor deficits. New learning was not affected once -opioid receptor levels replenished (Ͼ11 d after injection). In pretrained animals, ␤-FNA significantly impaired spatial memory retrieval and new (reversal) learning. These data are consistent with theoretical models of CA3 function and suggest that CA3 -opioid receptors play an important role in the acquisition and retrieval of spatial memory.
Introduction
The hippocampus is an essential neural structure involved in the formation of certain types of memory (Olton et al., 1978; Morris et al., 1982; Zola-Morgan et al., 1986) . For instance, temporary inactivation or lesions (Ն25%) of the dorsal hippocampus cause impairments in the acquisition and retrieval of spatial memory in tasks such as the Morris water maze (Moser et al., 1993; Moser and Moser, 1998; Riedel et al., 1999) . Furthermore, selective neurotoxic lesions of the CA3 region cause spatial learning and memory impairments (Handelmann and Olton, 1981; Sutherland et al., 1983; Stubley-Weatherly et al., 1996) , suggesting that this subregion of the hippocampus plays a significant role in spatial memory formation.
The leading synaptic model for information storage in the hippocampus is an activity-dependent form of synaptic plasticity called long-term potentiation (LTP) (Bliss and Collingridge, 1993) . Unlike the recurrent collaterals and medial perforant path, the type of LTP found at the mossy fiber to CA3 and lateral perforant path to CA3 or dentate synapses is not dependent on the activation of NMDA receptors (Harris and Cotman, 1986) , but instead, involve -opioid receptors (Bramham et al., 1988; Derrick et al., 1992; Bramham and Sarvey, 1996; Williams and Johnston, 1996) , among others (Yeckel et al., 1999; Lauri et al., 2001) . Opioid receptors (, , and ␦) are abundant in the hippocampus and are activated by opioid peptides, coreleased with glutamate, from mossy-fiber and lateral perforant path synapses (Stengaard-Pedersen, 1983; Mansour et al., 1987; Conner-Kerr et al., 1993) . Opioids are also known to modulate the excitability of hippocampal pyramidal neurons (Zieglgansberger et al., 1979; Simmons and Chavkin, 1996b) , whereas -opioid receptor antagonists (Breindl et al., 1994; Derrick and Martinez, 1994a; Bramham and Sarvey, 1996) or -opioid receptor gene deletions (Matthies et al., 2000; Jamot et al., 2003; Jang et al., 2003) block the induction of both mossy-fiber LTP to CA3 and lateralperforant-path LTP to CA3 and dentate and impair spatial water maze learning. However, the specific role of CA3 -opioid receptors has not been identified for spatial learning.
On the basis of lesion studies and anatomical features of the hippocampus, several computational models have been developed to study how the hippocampus acquires, encodes, and retrieves spatially and temporally coded information. It is believed that the CA3 region acts as an autoassociative network (Marr, 1971 ) that is capable of storing episodic memories, by virtue of its extensive recurrent collaterals (Ishizuka et al., 1990) , and that incoming information entering the CA3 via the mossy-fiber and perforant pathways play a critical role in the establishment and recall of context-dependent memories (McNaughton and Mor-ris, 1987; Rolls, 1992, 1994; Hasselmo et al., 1995) . The mossy-fiber input to CA3 is particularly important during learning and is often considered the "teaching synapse," whereas the perforant-path input to CA3 is thought necessary for recalling previously learned information Rolls, 1992, 1994) .
Although there are many computational models of CA3 function, there are few behavioral studies to support their predictions. Several models predict that temporary inactivation of the mossyfiber and perforant path to CA3 synapses would impair learning and retrieval of spatial memories Rolls, 1992, 1994) . We tested this hypothesis by training animals in a water maze task 24 hr or 11 d after a bilateral injection of saline or the selective and irreversible -opioid receptor antagonist ␤-funaltrexamine (␤-FNA) (Portoghese et al., 1980; Martin et al., 1993) into the dorsal CA3 region of the hippocampus. We also investigated the effects of ␤-FNA on spatial memory retrieval and new learning in pretrained animals. Control experiments were performed using a visual platform version of the water maze.
Materials and Methods
Animals. Male Sprague Dawley rats (350 -375 gm; Charles River, Wilmington, MA) were housed individually, provided with food and water ad libitum, and kept on a 12 hr light/dark cycle. To reduce stressmediated effects on behavior (Holscher, 1999) ; animals were allowed to rest for 1 week after arrival and were handled (1-2 min, three times a week) before surgery and training. All experimental protocols followed National Institutes of Health guidelines and were approved by the University of Texas at San Antonio Institutional Animal Care and Use Committee.
Surgical procedures. For permanent implantation of cannula, animals were anesthetized with 50 mg/kg sodium pentobarbital. Using standard stereotaxic techniques, bilateral 26 gauge stainless steel guide cannulas (model C315GA; Plastics One, Roanoke, VA) were implanted into the CA3 region of the dorsal hippocampus (anteroposterior, Ϫ3.5 mm; mediolateral, Ϯ3.8 mm; dorsoventral, Ϫ2.7 mm from the bregma) (Paxinos and Watson, 1998) . Each guide cannula was fitted with a dummy cannula extending 0.5 mm below the guide cannula to a final depth of 3.2 mm below the skull. Cannulas were permanently mounted to the skull with two to three head screws and dental cement. Animals received an intramuscular injection of penicillin (22500 U) into each thigh after the surgery and were given water treated with acetaminophen (0.32 mg/ml) for 3 d. Animals were allowed 5-7 d to recover from surgery before injections and training. For acute injections, an internal 33-gauge stainless steel cannula (model C315IA; Plastics One) was inserted extending 0.5 mm below the guide cannula to a final depth of 3.2 mm from the skull.
Drug injections. ␤-FNA was obtained from RBI Sigma (St. Louis, MO). Animals were anesthetized with sodium pentobarbital to ensure complete delivery of a single bilateral intrahippocampal injection of 0.9% saline or ␤-FNA (40 nmol in 0.9% saline, pH 7.4 -7.8). A stock solution of 12 mM ␤-FNA was first dissolved in water, then NaCl was added to achieve a 0.9% saline solution. Sodium hydroxide was used to adjust the pH. Both drug and saline were made up in pyrogen-free water. An equal volume (3.33 l) of either saline or ␤-FNA was administered at a rate of 0.333 l/min for 10 min through a 33-gauge internal cannula connected via polyethylene tubing to a 10 l Hamilton syringe. A Harvard syringe pump was used for delivery. Five minutes after the completion of the injections, the internal cannulas were removed and replaced with dummy cannulas. The experimenter was unaware of which animals received saline or ␤-FNA.
Behavioral training. Animals were trained in a Morris water maze (Morris et al., 1982) , consisting of a galvanized steel pool (150 cm diameter, 60 cm deep) filled with water (25 Ϯ 1°C) and made opaque with nontoxic water-soluble paint. Salient extramaze cues were placed on the walls around the room. The position of the animals during the task was monitored and recorded using a ceiling-mounted video camera connected to a computerized tracking/imaging analyzer system (HVSImage, Hampton, UK; Watermaze Software, Edinburgh, UK).
Experiment 1 investigated the effects of ␤-FNA on spatial learning performance and reversal learning after a 6 d retention interval (see Fig. 1A ). Experiment 2 investigated the effect of ␤-FNA on spatial learning 11 d after injection. Experiment 3 investigated the effect of ␤-FNA on visual platform training. Experiment 4 investigated the effects of ␤-FNA on memory retrieval and new learning in pretrained animals (see Fig. 5A ).
Animals were trained to find a single hidden platform (12 cm diameter) in one of four quadrants (NE, SE, SW, NW) that was submerged 3 cm below the water level. For each trial, animals were released into the water facing the edge of the pool from one of four equally spaced locations (N, S, E, W) in a pseudorandom order and allowed 60 sec to escape onto the platform. If the animals did not find the platform after 60 sec, they were guided to the platform, where they were allowed to remain for 15 sec. Each animal underwent five trials per day for 5 consecutive days. A spatial probe trial was conducted after the final training trial on days 1, 3, and 5, which consisted of a 60 sec swim trial in the absence of the platform. Six days after the last day of training (day 11), animals were given a single 60 sec probe trial to examine memory retention. Animals were then trained to find a hidden platform in the opposite quadrant for 5 additional days (reversal training). Spatial probe trials were performed on days 11, 13, and 15 of reversal training.
In experiment 1, animals began training 24 hr after injections of either saline (n ϭ 7) or ␤-FNA (n ϭ 7). Three saline control animals were removed from the study during the reversal training because of complications with the head stage. In experiment 2, an additional set of animals was trained in the water maze 11 d after receiving injections of ␤-FNA (n ϭ 5) or saline (n ϭ 7). Training consisted of five trials per day for 5 consecutive days. Spatial probe trials were given after the final training trial on days 1, 3, and 5. In experiment 3, an additional set of ␤-FNA (n ϭ 5) and saline-treated animals (n ϭ 4) were trained to find a visual platform raised 1.5 mm above the water. A ping-pong ball was attached 6 inches above the platform. Training consisted of five trials per day for 3 d. In experiment 4, animals underwent spatial pretraining consisting of five trials per day for 5 consecutive days. After the completion of pretraining, animals were matched and separated into two groups that had similar average escape latency values over the 5 d of training. One group (n ϭ 11; average escape latency, 20.8 Ϯ 3 sec) received ␤-FNA, whereas the control group (n ϭ 11; average escape latency, 21.0 Ϯ 2.8 sec) received an injection of 0.9% saline. Drug injections were administered on day 9, 2 d before the retrieval test and reversal training (see timeline in Fig. 5A ).
Statistical analysis. One-way and two-way repeated-measures ANOVAs were used to determine statistical significance of the drug treatment (␤-FNA or saline) as the between factor, and days of training and percentage of time spent in the probe trial quadrants or zones as the within factor. The StudentNewman-Keuls test was used to determine significance during preplanned post hoc analysis. Autoradiography. To determine the level and distribution of irreversible -opioid receptor binding by ␤-FNA, a separate group of naive animals were implanted with bilateral cannulas and injected with unlabeled ␤-FNA (40 nmol; n ϭ 4) or saline (n ϭ 4) (as described above). Half of the ␤-FNA and saline-treated animals then received a unilateral injection of ␤-FNA (40 nmol) containing 0.6 Ci of tritiated [
3 H]␤-FNA into the right cannula either 24 hr (␤-FNA, n ϭ 2; saline, n ϭ 2) or 11 d (␤-FNA, n ϭ 2; saline, n ϭ 2) after the unlabeled injection of ␤-FNA or saline. 3 H]␤-FNA infusion, and their brains were removed and frozen. Every third coronal section (20 m) was collected and thaw-mounted onto gelatin-coated slides. Slides were dried overnight at 4°C in a vacuum desiccator, and then stored at Ϫ20°C. Slides were washed at room temperature in series of 50 mM Tris-HCl, pH 7.4, baths for 1 and 5 min, and twice for 20 min (Liu-Chen et al., 1991) . Slides were briefly washed in water to remove salts and were dried quickly under cool air and exposed to film (Hyperfilm [ Histology. All animals from experiments 1-4 were killed and perfused with 4% formalin within 48 hr of the completion of the experiment. The brains of all animals were removed and stored in formalin for 2 d; they were then frozen and sectioned at Ϫ20°C. Coronal sections (25 m) were stained with the Nissl stain, thionine, to check for cannula placement. Data from animals with cannula misplacements during training were removed from the study (see below).
Results

Histology and autoradiography
After the completion of each experiment, animals were killed and their brains were removed for histological examination to determine cannula location. Inclusion of animals into the behavioral analysis was dependent on the cannula tips remaining within the CA3 region of the dorsal hippocampus. Cannula locations for experiment 1 are seen in Figure 1 B. Three animals were removed from this study because of cannula misplacements. Animals with cannulas located in the lateral ventricles (n ϭ 13) were analyzed separately and compared with animals having cannulas in the CA3 region.
␤-FNA is the ␤-fumaramate methyl ester of naltrexamine, first synthesized by Portoghese et al. (1980) . It is known to possess long-lasting irreversible -receptor antagonistic activity both in vitro (Portoghese et al., 1980; Takemori et al., 1981) and in vivo (Ward et al., 1982; Rothman et al., 1988; Martin et al., 1993) by covalently binding to lysine 233 in the third extracellular loop of the -opioid receptor (Chen et al., 1996) . Irreversible binding of (Fig. 1 D) .
Injection of ␤-FNA into the dorsal CA3 region impairs spatial learning
As outlined in Figure 1 A, animals in experiment 1 received a single injection of ␤-FNA (40 nmol; n ϭ 7) or saline (n ϭ 7) into the dorsal CA3 region of the hippocampus 24 hr before training in the reference memory version of the Morris water maze (Morris et al., 1982) . Inactivation of CA3 -opioid receptors with ␤-FNA significantly impaired the acquisition of spatial learning ( Fig. 2 A) compared with saline-treated controls. Saline control animals learned this task well, spending less time each day to find the platform and reaching asymptotic performance by the fourth day of training with escape latencies Ͻ20 sec, whereas the ␤-FNA-treated animals learned this task at a much slower rate. A two-way repeated-measures ANOVA of escape latencies found a significant treatment effect (F (1,12) ϭ 8.2; p ϭ 0.01), days effect (F (4,48) ϭ 15.9; p Ͻ 0.001), and no treatment ϫ days interaction (F (4,48) ϭ 0.59; p Ͼ 0.5). Similar impairments were seen in the swim distances (Fig. 2 B) (treatment effect, F (1,12) ϭ 5.1; p Ͻ 0.05; days effect, F (4,48) ϭ 10.5; p Ͻ 0.001) and in the percentage of time spent in the outer 20% of the pool, or thigmotaxis ( Fig. 2C ) (treatment effect, F (1,12) ϭ 5.69; p Ͻ 0.05; days effect, F (4,48) ϭ 20.0; p Ͻ 0.001). There were no differences in the latencies or distance to the platform on the first trial of day 1; moreover, no significant differences were found in swim speeds (Fig. 2 D) (treatment effect, F (1,14) ϭ 0.006; p Ͼ 0.5) or visible platform performance (Fig. 2 E) (treatment effect, F (1,7) ϭ 0.098; p Ͼ 0.5), suggesting that there were no overt behavioral deficits, such as an inability to swim or see the platform, as a result of the ␤-FNA injections.
To determine whether the learning impairments induced by ␤-FNA were specific for the -opioid receptors in the CA3 region of the hippocampus, spatial learning was tested in animals that had cannulas located in the lateral ventricles. Intraventricular injections of ␤-FNA did not impair spatial learning. There were no significant differences in the escape latencies between animals treated with saline (n ϭ 8) and ␤-FNA (n ϭ 5) (data not shown). A repeated-measures ANOVA of escape latencies revealed a significant days effect (F (4,44) ϭ 15.5; p Ͻ 0.001), but neither a significant treatment effect (F (1,11) ϭ 2.8; p Ͼ 0.1) nor a treatment ϫ days interaction (F (4,44) ϭ 0.14; p ϭ 0.97).
Inactivation of CA3 -opioid receptors with ␤-FNA significantly impaired the rate of spatial memory formation. A summary of the effects of ␤-FNA on probe trial performance, as measured by the percentage of time spent in the correct quadrant, is seen in Figure 2 F. Saline-and ␤-FNA-treated animals spent a similar amount of time in the correct quadrant during the first trial on day 1; however, by the end of the first day training (probe day 1) the saline-treated animals spent significantly more time in the correct quadrant ( p ϭ 0.007) compared with trial 1, whereas there was no change in the performance of the ␤-FNA-treated animals ( p Ͼ 0.1). In addition, ␤-FNA significantly impaired the rate of spatial memory formation measured over probe days 1, 3, and 5. A repeated-measures ANOVA of the percentage of time spent in the correct quadrant between the saline and ␤-FNAtreated animals showed a significant treatment effect (F (1,12) ϭ 10.6; p ϭ 0.007). Subsequent comparisons using the StudentNewman-Keuls test showed that the ␤-FNA-treated animals spent significantly less time in the correct quadrant than salinetreated animals ( p Ͻ 0.05) on probe days 1 and 3.
Although the ␤-FNA-treated animals were significantly impaired in the acquisition of this task, they eventually learned to locate the position of the platform by the last day of training (probe day 5) (Fig. 2 F) . Both saline-and ␤-FNA-treated animals spent significantly more time searching in the correct quadrant than all other quadrants during the 60 sec probe trial (one-way ANOVA; p Ͻ 0.001). A two-way repeated-measures ANOVA of the percentage of time spent in the four quadrants showed no significant treatment ϫ quadrant interaction (F (3, 36) ϭ 0.04; p Ͼ 0.5). Subsequent comparisons found no differences in the amount of time spent in the correct quadrant ( p Ͼ 0.1).
Injection of ␤-FNA into the dorsal CA3 region impairs spatial memory retention
Memory retention for the previously learned platform position was tested 6 d after the last day of training (11 d after injection) by giving animals a 60 sec probe trial (Fig. 3A) . Although the ␤-FNA-treated animals formed a spatial memory for the platform position by the last day of training (probe day 5) (Fig. 2 F) , this memory was not accessible. Only the saline-treated animals remembered the platform position, evidenced by spending significantly more time in the correct quadrant than in all other quadrants (one-way ANOVA; F (3, 18) ϭ 6.63; p ϭ 0.003), whereas the ␤-FNA-treated animals failed to show a quadrant preference (one-way ANOVA; F (3, 18) ϭ 1.25; p Ͼ 0.1). An example of the swim paths is seen in Figure 3B . The saline-treated animals spent 40.5 Ϯ 4.8% (means Ϯ SEM) of the time in the correct quadrant, whereas the ␤-FNA-treated animals performed at approximately chance levels by spending only 25.8 Ϯ 2.5% of the time in the correct quadrant. A two-way repeated-measures ANOVA of the percentage of time spent in the four quadrants between the saline and ␤-FNA-treated animals revealed a significant treatment ϫ quadrant interaction (F (3, 36) ϭ 4.5; p Ͻ 0.01). Subsequent comparisons using the Student-Newman-Keuls test revealed that the ␤-FNA-treated animals spent significantly less time in the correct quadrant ( p ϭ 0.002) than did saline control animals.
Reversal learning is not impaired once -opioid receptor levels replenish
To demonstrate that the learning impairments induced by ␤-FNA were reversible, we used a within-animal design to investigate whether the previously impaired ␤-FNA-treated animals could learn a new task once -opioid receptor levels replenished. As seen in Figure 1 D, at 11 d after injection there was an equivalent amount of -opioid receptor binding between saline-and ␤-FNA-treated animals. Therefore, immediately after the retention test on day 11, animals were trained to find a hidden platform in the opposite quadrant (reversal learning) for an additional 5 d (see Materials and Methods). . Performance on trial 1 is also shown. E, Latency to find a visible platform in a separate group of animals. Spatial probe trials were given after the last trial on the first, third, and fifth day of initial training. F, The rate of spatial memory formation was determined by monitoring the percentage of time spent in the correct quadrant during the first trial of day 1 and during the subsequent probe trials. The dashed line represents chance performance levels (25%). Significance differences were found. *p Ͻ 0.05 versus control; **p ϭ 0.007 versus trial 1.
Reversal learning was not impaired in the ␤-FNA-treated animals (Fig. 4 A) . Both saline and ␤-FNA-treated animals achieved the task, reaching asymptotic performance with escape latencies Ͻ12 sec by the end of training. A two-way repeated-measures ANOVA of escape latencies between the saline and ␤-FNAtreated animals revealed a significant days effect (F (4,36) ϭ 10.0; p Ͻ 0.001), but neither a significant treatment effect (F (1,9) ϭ 2.0; p Ͼ 0.1) nor a treatment ϫ days interaction (F (4,36) ϭ 0.11; p ϭ 0.98). Similar results were seen in the swim distances (Fig. 4 I) (treatment effect, F (1,9) ϭ 2.4; p Ͼ 0.1), thigmotaxis (treatment effect, F (1,9) ϭ 3.3; p Ͼ 0.1), and swim speeds (Fig. 4C ) (treatment effect, F (1,11) ϭ 0.016; p Ͼ 0.5). Moreover, reversal learning was not impaired in animals receiving injections of saline or ␤-FNA into the ventricles (latency data not shown; F (1,8) ϭ 0.03; p Ͼ 0.5). Spatial memory was not impaired in the ␤-FNA-treated animals during the reversal training, as evidenced by probe trial performance (Fig. 4 D) . A two-way repeated-measures ANOVA of the percentage of time spent in the correct quadrant over probe days 11, 13, and 15 revealed no significant treatment effect (F (1,9) ϭ 0.19; p Ͼ 0.5). Subsequent comparisons (Student-NewmanKeuls) showed that the saline and ␤-FNA-treated animals spent an equivalent amount of time in the correct quadrant ( p Ͼ 0.1) on all reversal probe days. However, it was noted that on probe day 11, the saline-treated animals were spending significantly more time searching in the correct quadrant than all other quadrants (one-way ANOVA; F (3, 9) ϭ 6.6; p Ͻ 0.05), unlike the ␤-FNA-treated animals (F (3, 9) ϭ 0.29; p Ͼ 0.5), suggesting that although -opioid receptor levels are equivalent between the saline and ␤-FNA-treated animals (Fig. 1 D) , ␤-FNA may still have some residual effect on spatial memory.
To investigate this finding further, an additional group of animals were trained in the water maze 11 d after receiving injections of either saline (n ϭ 7) or ␤-FNA (n ϭ 5) into the dorsal CA3 region of the hippocampus. As seen in Figure 4 E, spatial learning, as measured by escape latencies, was not impaired 11 d after injection. Both saline-and ␤-FNA-treated animals acquired the task, reaching asymptotic performance with escape latencies Ͻ15 sec by the end of training. A two-way repeated-measures ANOVA of escape latencies between the saline-and ␤-FNA-treated animals revealed a significant days effect (F (4,40) ϭ 37.0; p Ͻ 0.001), but neither a significant treatment effect (F (1,10) ϭ 2.6; p Ͼ 0.1), nor a treatment ϫ days interaction (F (4,40) ϭ 0.37; p Ͼ 0.5). There was no significant difference in escape latencies on the first trial of day 1. In contrast with the escape latencies, analysis of the swim distances (Fig. 4 F) revealed a significant treatment effect (F (1,10) ϭ 5.90; p Ͻ 0.05). Discrepancies between the escape latencies and swim distances could be attributed to differences in the swim speeds of the saline-and ␤-FNA-treated animals (Fig.  4G ), although this did not reach significance (F (1,10) ϭ 3.35; p ϭ 0.097).
The effect of ␤-FNA on spatial memory formation 11 d after injection, as measured by the percentage of time spent in the correct quadrant, is seen in Figure 4 H. ␤-FNA remains effective 11 d after injection, causing a significant impairment in spatial memory formation on probe day 1 but not on probe days 3 and 5. Saline-and ␤-FNA-treated animals spent a similar amount of time in the correct quadrant on the first trial of day 1. However, by the end of training on day 1 (probe day 1) there was a significant increase in the amount of time spent in the correct quadrant compared with trial 1 for the saline-treated animals ( p ϭ 0.005) but not for the ␤-FNA-treated animals ( p Ͼ 0.1). A two-way repeated-measures ANOVA of the percentage of time spent in the correct quadrant between the saline-and the ␤-FNA-treated animals showed a significant treatment effect (F (1,10) ϭ 6.0; p Ͻ 0.05) and a significant treatment ϫ probe day interaction (F (2,20) ϭ 3.5; p ϭ 0.05). Subsequent comparisons using the Student-Newman-Keuls test showed that the ␤-FNA-treated animals spent significantly less time in the correct quadrant than saline controls on probe day 1 ( p ϭ 0.001) but not on days 3 or 5 ( p Ͼ 0.5). These data are in agreement with the reversal learning data in experiment 1 (Fig.  4 D) .
Injections of ␤-FNA into the dorsal CA3 region impairs spatial memory retrieval
The previous findings suggest that the memory retention deficit observed in the ␤-FNA-treated animals (Fig. 3) may be attributable to an impairment in memory retrieval mechanisms. To investigate this finding further, animals were pretrained in the water maze in the absence of drug, then were given ␤-FNA 2 d before the retention test (Fig. 5A) . By the end of pretraining, both groups learned to locate the platform, reaching escape latencies Ͻ13 sec (Fig. 5C) . No significant group differences were found in escape latencies, distance to platform, thigmotaxis, or swim speeds (F (1,20) Ͻ 1 for each). Moreover, no significant differences were found in probe trial performance (Fig. 5D ) (treatment effect, F (1, 20) ϭ 0.61; p Ͼ 0.1).
Four days after the completion of pretraining (day 9), animals received a single bilateral injection of either 0.9% saline or ␤-FNA (40 nmol) into the dorsal hippocampal CA3 region. Two days later (day 11), animals were given a spatial probe test to determine the effects of ␤-FNA on spatial memory retrieval. As seen in Figure 5E , ␤-FNA treatment caused a significant impairment in spatial memory retrieval. Saline-treated pretrained animals focused their search predominantly in the correct quadrant, unlike the ␤-FNA-treated pretrained animals. A two-way repeatedmeasures ANOVA of the percentage of time spent in the four quadrants between the pretrained saline and ␤-FNA-treated animals found a significant treatment ϫ quadrant interaction (F (3, 60) ϭ 2.75; p ϭ 0.05). Analysis of the percentage of time spent searching within a 53 cm diameter zone around the platform location and corresponding zones (chance performance ϭ 12.5%) also found a significant treatment ϫ zone interaction (F (3, 60) ϭ 6.60; p Ͻ 0.001). Subsequent analysis using the Student-Newman-Keuls test showed that the ␤-FNA-treated pretrained animals spent significantly less time in the correct quadrant zone compared with the saline-treated animals ( p Ͻ 0.001).
Pretraining did not prevent spatial learning impairments induced by ␤-FNA treatment (Fig. 6 A-D) . Saline-treated animals took less time to locate the platform and spent less time in the outer 20% of the pool (thigmotaxis) compared with pretrained ␤-FNA-treated animals. A two-way repeated-measures ANOVA of escape latencies (Fig. 6 A) between the pretrained saline-and ␤-FNA-treated animals found a significant treatment effect (square root transformed, F (1, 20) F (4,80) ϭ 21.65; p Ͻ 0.001), but no treatment ϫ days interaction (F (4,80) ϭ 1.21; p Ͼ 0.1). Similar results were found for swim distances (Fig. 6 B) (treatment effect, F (1,20) ϭ 6.42; p Ͻ 0.05; days effect, F (4,80) ϭ 24.1; p Ͻ 0.001) and thigmotaxis ( Fig. 6C) (treatment effect, F (1,20) ϭ 9.96; p ϭ 0.005; days effect, F (4,80) ϭ 18.0; p Ͻ 0.001). Importantly, no significant differences in swim speeds were found during the reversal training (Fig. 6 D) (treatment effect, F (1,20) ϭ 1.34; p Ͼ 0.1) .
Despite the impaired performance, the pretrained ␤-FNAtreated animals formed a spatial memory for the new platform position (Fig. 6 E) . A two-way repeated-measures ANOVA of the percentage of time spent in the correct quadrant over probe days 11, 13, and 15 revealed no significant treatment effect (F (1,20) ϭ 1.38; p Ͼ 0.1). Although it seems that the pretrained ␤-FNAtreated animals spent less time in the correct quadrant than the pretrained saline-treated animals on probe day 11 (38.2 Ϯ 2.7 vs 44.1 Ϯ 4.5%, respectively) and day 13 (41.6 Ϯ 2.3 vs 44.2 Ϯ 3.9%, respectively), these differences were not significant ( p Ͼ 0.05).
Discussion
The present study shows that -opioid receptors in the dorsal CA3 region of the hippocampus play an important role in the acquisition and retrieval of spatial memory. Blocking -opioid receptors with ␤-FNA (40 nmol) significantly impairs the acquisition of spatial learning in both naive and pretrained animals, as measured by escape latency, without causing sensorimotor deficits. ␤-FNA also significantly impairs the rate of spatial memory formation and causes memory retrieval deficits after a 6 d retention interval, as measured by probe trial performance. Animals are, however, able to learn a new task once receptor levels replenish. These data are in agreement with computational models of CA3 function (McNaughton and Morris, 1987; Hasselmo et al., 1995; Kesner et al., 2000) and supports the hypothesis that the mossy-fiber and perforant pathways to CA3 are important for spatial learning and memory retrieval (Treves and Rolls, 1994) .
One of the advantages of using ␤-FNA in this study was that it produced a long-lasting antagonism of -opioid receptors after a single injection. The results of the receptor binding studies show that a single application of ␤-FNA (40 nmol) depleted -opioid receptors in the CA3 region to 50.8% of control levels 24 hr after injection. However, by 11 d after injection, -opioid receptor levels returned to 86.9% of control levels. These results are consistent with studies by Martin et al. (1995 Martin et al. ( , 1998 , who showed that intracerebroventricular injections of ␤-FNA (40 nmol) effectively reduced [ ]-enkephalin binding to -opioid receptors by 34 -50% in the rat brain 24 hr after injection, and estimated the half-life of recovery of -opioid receptors to be 10.3 Ϯ 1.4 (mean Ϯ SEM) d. The time course of the inhibitory effects of ␤-FNA on spatial learning observed here are consistent with antagonistic effects of ␤-FNA found in rats trained to self-administer heroin (Martin et al., 1995 (Martin et al., , 1998 , suggesting that the behavioral responses (i.e., learning and self-administration) return at a rate that parallels the return of functional -opioid-receptor binding sites. Given the location of the injections and spread of ␤-FNA (Fig. 1B,C) it is possible that in some animals ␤-FNA may have reached the molecular layer of the dentate gyrus; however, our judgment is that the observed learning deficits are most likely attributable to the blockade of CA3 -opioid receptors. The role of -opioid receptors in the dentate gyrus for spatial learning remains to be determined.
The results of this study are similar to those of Handelmann and Olton (1981) and others (Sutherland et al., 1983; StubleyWeatherly et al., 1996; Steffenach et al., 2002) , who showed that . D, The percentage of time spent in the correct quadrant was determined (means Ϯ SEM) during reversal probe trials on days 11, 13, and 15. Escape latency ( E), distance traveled ( F), and swim speed ( G) for a separate group of animals trained in the water maze for 5 consecutive days starting 11 d after injection. Spatial probe trials were given after the first, third, and fifth day of training. H, The percentage of time spent in the correct quadrant during the during the probe trials and on the first trial of day 1. The dashed line represents chance performance levels (25%). Significant differences were found.
# p ϭ 0.005 versus trial 1; *p ϭ 0.001 versus saline control.
the integrity of CA3 pyramidal cells or the synaptic connections within the CA3 region are important for spatial learning in both naive or pretrained animals. Using a within-animal design, we showed that ␤-FNA significantly impaired spatial learning while -opioid receptors in the CA3 region were blocked and that animals could learn a new task once -receptors levels replenished. The later results were confirmed with a second group of animals trained 11 d after injection (Fig. 4) .
In both naive and pretrained animals, ␤-FNA caused a significant impairment in escape latencies and swim distances (Figs. 2,  6 ). The spatial learning impairments induced by ␤-FNA were specific for the CA3 region, because injections of ␤-FNA into the lateral ventricles did not impair spatial learning. This is consistent with findings by Martin et al. (1993) , who showed that intracerebroventricular injections of ␤-FNA (40 nmol) did not significantly reduce -opioid receptors in the hippocampus (fields CA1-CA3) or dentate gyrus. Moreover, the observed acquisition impairments were not caused by sensorimotor deficits commonly seen in the presence of NMDA-receptor antagonists (Morris, 1989; Saucier and Cain, 1995; Saucier et al., 1996) , because there were no differences in the ability of the ␤-FNA-treated animals to climb onto the platform once found (experimenter's observation); there were no differences in swim speeds (Figs. 2 D, 6D) or visual platform learning (Fig. 2 E) .
␤-FNA-treated animals did, however, take a more circuitous route to locate the platform, leading to an increased thigmotaxic behavior in both naive (Fig. 2C ) and pretrained animals (Fig. 6C ). This circuitous behavior does not imply that ␤-FNA causes sensorimotor deficits Hoh et al., 1999) , but instead may reflect a shift from using a spatial search strategy to locate the platform, to a more praxic or taxic strategy (O'Keefe and Nadel, 1978) . Similar changes in search strategy (i.e., increased thigmotaxic behavior) are commonly seen in hippocampal lesioned naive and pretrained animals (Sutherland et al., 1983; DiMattia and Kesner, 1988) . Together, these results suggest that regardless of previous experience, -opioid receptors in the dorsal CA3 region play a significant role in the acquisition of spatial water maze learning; however, pretraining prevents the ␤-FNA-induced memory impairments as measured by probe trial performance.
Inactivation of -opioid receptors with ␤-FNA significantly impaired the rate of spatial memory formation during the initial training (Fig. 2 F) . The inability of the ␤-FNA-treated animals to form a longlasting spatial memory at a rate comparable with saline-treated controls suggests that there is a deficit in opioid-receptordependent plasticity. -Opioid receptor activation is critical for the induction of LTP in both the mossy-fiber and lateral perforant path synapses to CA3 (Derrick et al., 1992; Derrick and Martinez, 1994a; Williams and Johnston, 1996) , whereas -opioid receptor activation blocks mossy-fiber LTP (Weisskopf et al., 1993; Simmons and Chavkin, 1996a) . As stated previously, ␤-FNA has long-lasting (Ͼ48 hr) -opioid receptor antagonistic activities in addition to short-term (Ͻ3-6 hr) -opioid receptor agonistic activities (Ward et al., 1982) . One can argue that the observed effects of ␤-FNA in the present study are attributable to its possible agonistic action on -opioid receptors, because repeated intrahippocampal injections of the -agonist dynorphin impairs water maze learning in rats (McDaniel et al., 1990; Figure 5 . Effects of ␤-FNA on spatial memory retrieval in pretrained animals. A, A separate group of animals was first pretrained, then injected with ␤-FNA or saline 2 d before a retrieval test and reversal training. B, Location of cannula tips for the animals treated with ␤-FNA (filled circles) and saline (open circles). Plates were adapted from Paxinos and Watson (1998) . C, Escape latency during spatial pretraining (in the absence of drug) between the animals to be treated with ␤-FNA (filled circles) or saline (open squares). D, The percentage of time spent in the correct quadrant during the pretraining probe trials (means Ϯ SEM). Effects of ␤-FNA on spatial memory retrieval for the previously learned platform position (E, F ). The percentage of time spent in the correct and the three other corresponding quadrants ( E), or within a 53 cm diameter zone around the platform ( F), was determined (means Ϯ SEM) for the animals treated with ␤-FNA (black columns) and saline (white columns). Note that the pretrained ␤-FNA-treated animals are spending close to chance levels in all quadrants (25%) and zones (12.5%). The right column in E shows representative swim paths for animals treated with saline (top) and ␤-FNA (bottom). Significant differences were found.
# p ϭ 0.05; *p Ͻ 0.05 versus saline control; **p Ͻ 0.05 versus all other quadrants or zones. The dashed line outlines correct quadrant. Sandin et al., 1998) . Although possible, this seems unlikely, because the short-term -agonistic activity of ␤-FNA (Ͻ3-6 hr) would not account for the impaired probe trial performance seen up to 11 d after injection. Therefore, spatial memory impairments caused by ␤-FNA are likely caused by the long-lasting inactivation of -opioid receptors and subsequent blockade of -opioid-receptor-dependent plasticity. This conclusion is further supported by the recent findings showing impairments in the induction of both mossy-fiber LTP to CA3, lateral perforant path LTP to CA3 and dentate, and impairments in spatial water maze learning in certain strains of -opioid-receptor-deficient mice (Matthies et al., 2000; Jamot et al., 2003; Jang et al., 2003) .
Although the ␤-FNA-treated animals formed a spatial memory for the platform location by probe day 5 (Fig. 2 F) , this memory was not stable, and a significant amount of forgetting occurred over a 6 d retention period compared with saline-treated controls (Fig. 3A) . Because the effects of ␤-FNA could still be seen 11 d after injection (Fig. 4 H) , an alternative explanation for the poor retention test performance by the ␤-FNA-treated animals was that there was a memory retrieval deficit. We confirmed this finding by first pretraining animals, then giving ␤-FNA or saline 2 d before the retention test (Fig. 5) , and indeed found a retrieval deficit in the ␤-FNA-treated animals. Together, these data are consistent with previous lesion studies demonstrating that the integrity of the CA3 region is necessary for the retrieval of spatial memory (Handelmann and Olton, 1981; Stubley-Weatherly et al., 1996; Steffenach et al., 2002) , and suggests that CA3 -opioid receptors play an important role in spatial memory retrieval.
Our behavioral findings are in agreement with several computational models predicting the function of the CA3 region in memory encoding and retrieval (Marr, 1971; McNaughton and Morris, 1987; Treves and Rolls, 1994; Hasselmo et al., 1995) . For instance, studies by Rolls (1992, 1994) predict that temporary inactivation of the mossy-fiber and perforant pathways to CA3 would impair new learning by preventing the activation of CA3 pyramidal cells and altering the subsequent synaptic modifications occurring at the CA3 recurrent and perforant path synapses. The mossy-fiber synapses are thought to be particularly important during learning, because of their large size and potential to initiate CA3 firing, which drives or forces network output. Interestingly, Henze et al. (2002) recently found that a single dentate granule cell is capable of inducing firing in CA3 pyramidal cells, in vivo, after high-frequency stimulation (100 Hz) or behaviorally relevant stimulation containing highfrequency episodes. This is intriguing, because high-frequency stimulation is necessary for the release of opioid peptides (Wagner et al., 1990) and for the induction of mossy-fiber and lateralperforant-path LTP (Derrick and Martinez, 1994b; Williams and Johnston, 1996; Do et al., 2002) . Indeed, we found that blocking -opioid receptors in the dorsal hippocampal CA3 region significantly impaired the acquisition of a spatial water maze task and impaired performance on spatial probe trials.
One of the proposed computational functions of the CA3 region is pattern completion (Marr, 1971; McNaughton and Morris, 1987) ; that is, when the CA3 is presented with a partial sequence of events (or spatial cues), the CA3 is able to recreate the complete pattern of events by activating the recurrent collaterals. The model proposed by Rolls, 1992, 1994; Rolls, 1996) suggests that the perforant path, but not the mossy-fiber pathway to CA3, is necessary for the retrieval of episodic memory. Although our data do not allow us to distinguish between the pathways, ␤-FNA treatment may have prevented the synaptic modifications occurring at the mossy-fiber and lateral perforant path to CA3 synapses during learning, in addition to preventing the activation of synapses necessary for the retrieval of memory. Possible mechanisms include disrupting synaptic transmission or plasticity in these pathways (Przewlocki et al., 1999; Kearns et al., 2001) or altering the excitability of CA3 pyramidal cells by modulating GABAergic inhibition (Martinez et al., 1979; Zieglgansberger et al., 1979; Jin and Chavkin, 1999) . Unlike -opioid receptors, genetic (Nakazawa et al., 2002) or pharmacological blockage (Lee and Kesner, 2002) of CA3 NMDA receptors do not impair spatial water maze learning or memory retrieval when tested in the same environment used for training, suggesting a differential role for CA3 -opioid and NMDA receptors. . E, The percentage of time spent in the correct quadrant was determined (mean Ϯ SEM) during reversal probe trials on days 11, 13, and 15. The dashed line represents chance performance levels (25%).
